New

Create, analyze, optimize your ETF portfolio. Start now →

RSPHvsVHTETF Comparison

ETF 1
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.03%
VS
ETF 2
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
+0.03%

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) and Vanguard Health Care ETF (VHT) belong to the same industry segment: US Health Care. RSPH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, VHT's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. RSPH is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.09% for VHT. RSPH is up 25.34% year-to-date (YTD) with +$61M in YTD flows. VHT performs worse with 20.23% YTD performance, and +$135M in YTD flows. Run a side-by-side ETF comparison of RSPH and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

RSPH vs VHT performance and flow charts

Performance

-2.00.02.04.06.08.0%Sep 30Oct 7Oct 14Oct 21Oct 28

Cumulative Flows

-100 M-50 M0 M50 MSep 30Oct 7Oct 14Oct 21Oct 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/30/2026
1M3MYTD1Y3Y5Y
Perf.
RSPH
VHT
+7.26%+8.39%
+13.92%+11.88%
+25.34%+20.23%
+32.12%+28.93%
+60.29%+59.89%
+32.89%+42.25%
Flows
RSPH
VHT
+$45M+$28M
+$104M+$219M
+$61M+$135M
+$57M+$275M
-$224M-$1.98B
-$206M-$935M
Volatility and drawdown
3M1Y3Y5Y
Volatility
RSPH
VHT
+18.23%+16.52%
+16.84%+15.95%
+15.92%+14.86%
+16.81%+15.65%
Max drawdown
RSPH
VHT
-5.57%-5.63%
-10.87%-10.39%
-16.96%-16.88%
-21.91%-17.77%
Max drawdown duration
RSPH
VHT
55d56d
116d169d
434d435d
817d767d
Trading data

Create an account to view trading data

Join for free
RSPH
VHT
Last sale
11/2/2026 at 2:30 PM
$39.90
$341.27
Previous close
10/30/2026
$39.69
$342.33
Consolidated volume
10/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
RSPH
VHT
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/2/2026 at 2:30 PM
Live
Closed
RSPH
VHT
Last price
$39.90
$341.27
1D performance
+0.53%
-0.31%
AuM$982.79 M$20.74 B
E/R0.4%0.09%
Characteristics
RSPH
VHT
Management strategyPassivePassive
ProviderInvescoVanguard
BenchmarkS&P 500 Equal Weight Health Care IndexMSCI US IMI Health Care 25/50 Index
N° of holdings60408
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2006January 26, 2004
ESGNoNo
Advertisement
Exposure

Countries

RSPH
USA
96.84%
Other
3.16%
VHT
USA
96.83%
Other
3.17%

Sectors

RSPH
Healthcare
98.51%
Other
1.49%
VHT
Healthcare
97.77%
Other
2.23%
Advertisement

Diversification

RSPH

Total weight of top 15 holdings out of 15

28.14%
VHT

Total weight of top 15 holdings out of 15

60.91%

Top 15 holdings

Data as of September 30, 2026
RSPH
Moderna, Inc.
2.35%
Illumina, Inc.
2.14%
Revvity, Inc.
1.97%
Agilent Technologies, Inc.
1.96%
Mettler-Toledo International, Inc.
1.94%
Intuitive Surgical, Inc.
1.90%
Thermo Fisher Scientific, Inc.
1.81%
West Pharmaceutical Services, Inc.
1.80%
Danaher Corp.
1.79%
Viatris, Inc.
1.79%
Waters Corp.
1.77%
Biogen, Inc.
1.75%
Veeva Systems, Inc.
1.74%
Amgen, Inc.
1.73%
AbbVie, Inc.
1.71%
VHT
Eli Lilly & Co.
12.93%
Johnson & Johnson
8.78%
AbbVie, Inc.
6.45%
Merck & Co., Inc.
5.01%
UnitedHealth Group, Inc.
4.65%
Thermo Fisher Scientific, Inc.
3.50%
Amgen, Inc.
3.18%
Gilead Sciences, Inc.
2.58%
Abbott Laboratories
2.40%
Pfizer Inc.
2.27%
Intuitive Surgical, Inc.
2.01%
Danaher Corp.
1.97%
Vertex Pharmaceuticals, Inc.
1.85%
Bristol Myers Squibb Co.
1.78%
Medtronic Plc
1.54%
Frequently asked questions about RSPH and VHT

How have the RSPH and VHT ETFs performed in 2026?

As of October 30, 2026, RSPH is up 25.34% year-to-date (YTD), while VHT has returned 20.23%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or VHT?

Year-to-date, the RSPH ETF saw +$61M in flows, compared to +$135M for VHT.

Which ETF is more volatile: RSPH or VHT?

Over the past year, RSPH had a volatility of 16.84%, while VHT experienced 15.95%.

Which ETF is bigger: RSPH or VHT?

As of October 30, 2026, RSPH holds $982.79 M in assets under management (AUM), while VHT manages $20.74 B.

What sectors do the RSPH and VHT ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, VHT focuses on Healthcare.

What are the top holdings of the RSPH ETF and VHT ETF?

RSPH top holdings include Moderna, Inc., Illumina, Inc. and Revvity, Inc.. VHT holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: RSPH or VHT?

RSPH holds 60 securities with 28.14% of its assets in the top 15. VHT has 408 securities and a top 15 weight of 60.91%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026